Report Cover

Global Oral Vaccines Market Growth 2020-2025


According to this study, over the next five years the Oral Vaccines market will register a 7.4%% CAGR in terms of revenue, the global market size will reach $ 3020.1 million by 2025, from $ 2272.8 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Oral Vaccines business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Vaccines market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Oral Vaccines, covering the supply chain analysis, impact assessment to the Oral Vaccines market size growth rate in several scenarios, and the measures to be undertaken by Oral Vaccines companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
    Rotavirus Vaccine
    Cholera Vaccine
    Oral Polio Vaccine
    Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
    Public
    Private

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
    Merck
    Vabiotech
    GSK
    Lanzhou Institute
    Serum Institute
    Sanofi
    Bibcol
    Valneva
    PaxVax
    Shanghai United Cell
    Tiantan Biological
    Bio-Med
    Panacea Biotec Ltd
    Halfkin Bio-Pharmaceuticals
    EuBiologics

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
    To study and analyze the global Oral Vaccines consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
    To understand the structure of Oral Vaccines market by identifying its various subsegments.
    Focuses on the key global Oral Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Oral Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the consumption of Oral Vaccines submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
    1.1 Market Introduction
    1.2 Research Objectives
    1.3 Years Considered
    1.4 Market Research Methodology
    1.5 Data Source
    1.6 Economic Indicators
    1.7 Currency Considered

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Oral Vaccines Consumption 2015-2025
        2.1.2 Oral Vaccines Consumption CAGR by Region
    2.2 Oral Vaccines Segment by Type
        2.2.1 Rotavirus Vaccine
        2.2.2 Cholera Vaccine
        2.2.3 Oral Polio Vaccine
        2.2.4 Others
    2.3 Oral Vaccines Consumption by Type
        2.3.1 Global Oral Vaccines Consumption Market Share by Type (2015-2020)
        2.3.2 Global Oral Vaccines Revenue and Market Share by Type (2015-2020)
        2.3.3 Global Oral Vaccines Sale Price by Type (2015-2020)
    2.4 Oral Vaccines Segment by Application
        2.4.1 Public
        2.4.2 Private
    2.5 Oral Vaccines Consumption by Application
        2.5.1 Global Oral Vaccines Consumption Market Share by Type (2015-2020)
        2.5.2 Global Oral Vaccines Value and Market Share by Type (2015-2020)
        2.5.3 Global Oral Vaccines Sale Price by Type (2015-2020)

3 Global Oral Vaccines by Company
    3.1 Global Oral Vaccines Sales Market Share by Company
        3.1.1 Global Oral Vaccines Sales by Company (2018-2020)
        3.1.2 Global Oral Vaccines Sales Market Share by Company (2018-2020)
    3.2 Global Oral Vaccines Revenue Market Share by Company
        3.2.1 Global Oral Vaccines Revenue by Company (2018-2020)
        3.2.2 Global Oral Vaccines Revenue Market Share by Company (2018-2020)
    3.3 Global Oral Vaccines Sale Price by Company
    3.4 Global Oral Vaccines Manufacturing Base Distribution, Sales Area, Type by Company
        3.4.1 Global Oral Vaccines Manufacturing Base Distribution and Sales Area by Company
        3.4.2 Players Oral Vaccines Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion

4 Oral Vaccines by Regions
    4.1 Oral Vaccines by Regions
    4.2 Americas Oral Vaccines Consumption Growth
    4.3 APAC Oral Vaccines Consumption Growth
    4.4 Europe Oral Vaccines Consumption Growth
    4.5 Middle East & Africa Oral Vaccines Consumption Growth

5 Americas
    5.1 Americas Oral Vaccines Consumption by Countries
        5.1.1 Americas Oral Vaccines Consumption by Countries (2015-2020)
        5.1.2 Americas Oral Vaccines Value by Countries (2015-2020)
    5.2 Americas Oral Vaccines Consumption by Type
    5.3 Americas Oral Vaccines Consumption by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
    5.8 Key Economic Indicators of Few Americas Countries

6 APAC
    6.1 APAC Oral Vaccines Consumption by Regions
        6.1.1 APAC Oral Vaccines Consumption by Regions (2015-2020)
        6.1.2 APAC Oral Vaccines Value by Regions (2015-2020)
    6.2 APAC Oral Vaccines Consumption by Type
    6.3 APAC Oral Vaccines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
    7.1 Europe Oral Vaccines by Countries
        7.1.1 Europe Oral Vaccines Consumption by Countries (2015-2020)
        7.1.2 Europe Oral Vaccines Value by Countries (2015-2020)
    7.2 Europe Oral Vaccines Consumption by Type
    7.3 Europe Oral Vaccines Consumption by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
    7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
    8.1 Middle East & Africa Oral Vaccines by Countries
        8.1.1 Middle East & Africa Oral Vaccines Consumption by Countries (2015-2020)
        8.1.2 Middle East & Africa Oral Vaccines Value by Countries (2015-2020)
    8.2 Middle East & Africa Oral Vaccines Consumption by Type
    8.3 Middle East & Africa Oral Vaccines Consumption by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers and Impact
        9.1.1 Growing Demand from Key Regions
        9.1.2 Growing Demand from Key Applications and Potential Industries
    9.2 Market Challenges and Impact
    9.3 Market Trends

10 Marketing, Distributors and Customer
    10.1 Sales Channel
        10.1.1 Direct Channels
        10.1.2 Indirect Channels
    10.2 Oral Vaccines Distributors
    10.3 Oral Vaccines Customer

11 Global Oral Vaccines Market Forecast
    11.1 Global Oral Vaccines Consumption Forecast (2021-2025)
    11.2 Global Oral Vaccines Forecast by Regions
        11.2.1 Global Oral Vaccines Forecast by Regions (2021-2025)
        11.2.2 Global Oral Vaccines Value Forecast by Regions (2021-2025)
        11.2.3 Americas Consumption Forecast
        11.2.4 APAC Consumption Forecast
        11.2.5 Europe Consumption Forecast
        11.2.6 Middle East & Africa Consumption Forecast
    11.3 Americas Forecast by Countries
        11.3.1 United States Market Forecast
        11.3.2 Canada Market Forecast
        11.3.3 Mexico Market Forecast
        11.3.4 Brazil Market Forecast
   11.4 APAC Forecast by Countries
        11.4.1 China Market Forecast
        11.4.2 Japan Market Forecast
        11.4.3 Korea Market Forecast
        11.4.4 Southeast Asia Market Forecast
        11.4.5 India Market Forecast
        11.4.6 Australia Market Forecast
    11.5 Europe Forecast by Countries
        11.5.1 Germany Market Forecast
        11.5.2 France Market Forecast
        11.5.3 UK Market Forecast
        11.5.4 Italy Market Forecast
        11.5.5 Russia Market Forecast
    11.6 Middle East & Africa Forecast by Countries
        11.6.1 Egypt Market Forecast
        11.6.2 South Africa Market Forecast
        11.6.3 Israel Market Forecast
        11.6.4 Turkey Market Forecast
        11.6.5 GCC Countries Market Forecast
    11.7 Global Oral Vaccines Forecast by Type
    11.8 Global Oral Vaccines Forecast by Application

12 Key Players Analysis
    12.1 Merck
        12.1.1 Company Information
        12.1.2 Oral Vaccines Product Offered
        12.1.3 Merck Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
        12.1.4 Main Business Overview
        12.1.5 Merck Latest Developments
    12.2 Vabiotech
        12.2.1 Company Information
        12.2.2 Oral Vaccines Product Offered
        12.2.3 Vabiotech Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
        12.2.4 Main Business Overview
        12.2.5 Vabiotech Latest Developments
    12.3 GSK
        12.3.1 Company Information
        12.3.2 Oral Vaccines Product Offered
        12.3.3 GSK Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
        12.3.4 Main Business Overview
        12.3.5 GSK Latest Developments
    12.4 Lanzhou Institute
        12.4.1 Company Information
        12.4.2 Oral Vaccines Product Offered
        12.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
        12.4.4 Main Business Overview
        12.4.5 Lanzhou Institute Latest Developments
    12.5 Serum Institute
        12.5.1 Company Information
        12.5.2 Oral Vaccines Product Offered
        12.5.3 Serum Institute Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
        12.5.4 Main Business Overview
        12.5.5 Serum Institute Latest Developments
    12.6 Sanofi
        12.6.1 Company Information
        12.6.2 Oral Vaccines Product Offered
        12.6.3 Sanofi Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
        12.6.4 Main Business Overview
        12.6.5 Sanofi Latest Developments
    12.7 Bibcol
        12.7.1 Company Information
        12.7.2 Oral Vaccines Product Offered
        12.7.3 Bibcol Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
        12.7.4 Main Business Overview
        12.7.5 Bibcol Latest Developments
    12.8 Valneva
        12.8.1 Company Information
        12.8.2 Oral Vaccines Product Offered
        12.8.3 Valneva Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
        12.8.4 Main Business Overview
        12.8.5 Valneva Latest Developments
    12.9 PaxVax
        12.9.1 Company Information
        12.9.2 Oral Vaccines Product Offered
        12.9.3 PaxVax Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
        12.9.4 Main Business Overview
        12.9.5 PaxVax Latest Developments
    12.10 Shanghai United Cell
        12.10.1 Company Information
        12.10.2 Oral Vaccines Product Offered
        12.10.3 Shanghai United Cell Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
        12.10.4 Main Business Overview
        12.10.5 Shanghai United Cell Latest Developments
    12.11 Tiantan Biological
        12.11.1 Company Information
        12.11.2 Oral Vaccines Product Offered
        12.11.3 Tiantan Biological Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
        12.11.4 Main Business Overview
        12.11.5 Tiantan Biological Latest Developments
    12.12 Bio-Med
        12.12.1 Company Information
        12.12.2 Oral Vaccines Product Offered
        12.12.3 Bio-Med Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
        12.12.4 Main Business Overview
        12.12.5 Bio-Med Latest Developments
    12.13 Panacea Biotec Ltd
        12.13.1 Company Information
        12.13.2 Oral Vaccines Product Offered
        12.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
        12.13.4 Main Business Overview
        12.13.5 Panacea Biotec Ltd Latest Developments
    12.14 Halfkin Bio-Pharmaceuticals
        12.14.1 Company Information
        12.14.2 Oral Vaccines Product Offered
        12.14.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
        12.14.4 Main Business Overview
        12.14.5 Halfkin Bio-Pharmaceuticals Latest Developments
    12.15 EuBiologics
        12.15.1 Company Information
        12.15.2 Oral Vaccines Product Offered
        12.15.3 EuBiologics Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
        12.15.4 Main Business Overview
        12.15.5 EuBiologics Latest Developments

13 Research Findings and Conclusion

List of Tables Table 1. Research Methodology Table 2. Data Source Table 3. Oral Vaccines Consumption CAGR by Region 2015-2025 ($ Millions) Table 4. Major Players of Rotavirus Vaccine Table 5. Major Players of Cholera Vaccine Table 6. Major Players of Oral Polio Vaccine Table 7. Major Players of Others Table 8. Global Consumption Sales by Type (2015-2020) Table 9. Global Oral Vaccines Consumption Market Share by Type (2015-2020) Table 10. Global Oral Vaccines Revenue by Type (2015-2020) ($ million) Table 11. Global Oral Vaccines Value Market Share by Type (2015-2020) ($ Millions) Table 12. Global Oral Vaccines Sale Price by Type (2015-2020) Table 13. Global Consumption Sales by Application (2015-2020) Table 14. Global Oral Vaccines Consumption Market Share by Application (2015-2020) Table 15. Global Oral Vaccines Value by Application (2015-2020) Table 16. Global Oral Vaccines Value Market Share by Application (2015-2020) Table 17. Global Oral Vaccines Sale Price by Application (2015-2020) Table 18. Global Oral Vaccines Sales by Company (2017-2019) (M Doses) Table 19. Global Oral Vaccines Sales Market Share by Company (2017-2019) Table 20. Global Oral Vaccines Revenue by Company (2017-2019) ($ Millions) Table 21. Global Oral Vaccines Revenue Market Share by Company (2017-2019) Table 22. Global Oral Vaccines Sale Price by Company (2017-2019) Table 23. Global Oral Vaccines Manufacturing Base Distribution and Sales Area by Manufacturers Table 24. Players Oral Vaccines Products Offered Table 25. Oral Vaccines Concentration Ratio (CR3, CR5 and CR10) (2017-2019) Table 26. Global Oral Vaccines Consumption by Regions 2015-2020 (M Doses) Table 27. Global Oral Vaccines Consumption Market Share by Regions 2015-2020 Table 28. Global Oral Vaccines Value by Regions 2015-2020 ($ Millions) Table 29. Global Oral Vaccines Value Market Share by Regions 2015-2020 Table 30. Americas Oral Vaccines Consumption by Countries (2015-2020) (M Doses) Table 31. Americas Oral Vaccines Consumption Market Share by Countries (2015-2020) Table 32. Americas Oral Vaccines Value by Countries (2015-2020) ($ Millions) Table 33. Americas Oral Vaccines Value Market Share by Countries (2015-2020) Table 34. Americas Oral Vaccines Consumption by Type (2015-2020) (M Doses) Table 35. Americas Oral Vaccines Consumption Market Share by Type (2015-2020) Table 36. Americas Oral Vaccines Consumption by Application (2015-2020) (M Doses) Table 37. Americas Oral Vaccines Consumption Market Share by Application (2015-2020) Table 38. APAC Oral Vaccines Consumption by Countries (2015-2020) (M Doses) Table 39. APAC Oral Vaccines Consumption Market Share by Countries (2015-2020) Table 40. APAC Oral Vaccines Value by Regions (2015-2020) ($ Millions) Table 41. APAC Oral Vaccines Value Market Share by Regions (2015-2020) Table 42. APAC Oral Vaccines Consumption by Type (2015-2020) (M Doses) Table 43. APAC Oral Vaccines Consumption Market Share by Type (2015-2020) Table 44. APAC Oral Vaccines Consumption by Application (2015-2020) (M Doses) Table 45. APAC Oral Vaccines Consumption Market Share by Application (2015-2020) Table 46. Europe Oral Vaccines Consumption by Countries (2015-2020) (M Doses) Table 47. Europe Oral Vaccines Consumption Market Share by Countries (2015-2020) Table 48. Europe Oral Vaccines Value by Countries (2015-2020) ($ Millions) Table 49. Europe Oral Vaccines Value Market Share by Countries (2015-2020) Table 50. Europe Oral Vaccines Consumption by Type (2015-2020) (M Doses) Table 51. Europe Oral Vaccines Consumption Market Share by Type (2015-2020) Table 52. Europe Oral Vaccines Consumption by Application (2015-2020) (M Doses) Table 53. Europe Oral Vaccines Consumption Market Share by Application (2015-2020) Table 54. Middle East & Africa Oral Vaccines Consumption by Countries (2015-2020) (M Doses) Table 55. Middle East & Africa Oral Vaccines Consumption Market Share by Countries (2015-2020) Table 56. Middle East & Africa Oral Vaccines Value by Countries (2015-2020) ($ Millions) Table 57. Middle East & Africa Oral Vaccines Value Market Share by Countries (2015-2020) Table 58. Middle East & Africa Oral Vaccines Consumption by Type (2015-2020) (M Doses) Table 59. Middle East & Africa Oral Vaccines Consumption Market Share by Type (2015-2020) Table 60. Middle East & Africa Oral Vaccines Consumption by Application (2015-2020) (M Doses) Table 61. Middle East & Africa Oral Vaccines Consumption Market Share by Application (2015-2020) Table 62. Oral Vaccines Distributors List Table 63. Oral Vaccines Customer List Table 64. Global Oral Vaccines Consumption Forecast by Countries (2021-2025) (M Doses) Table 65. Global Oral Vaccines Consumption Market Forecast by Regions Table 66. Global Oral Vaccines Value Forecast by Countries (2021-2025) ($ Millions) Table 67. Global Oral Vaccines Value Market Share Forecast by Regions Table 68. Global Oral Vaccines Consumption Forecast by Type (2021-2025) (M Doses) Table 69. Global Oral Vaccines Consumption Market Share Forecast by Type (2021-2025) Table 70. Global Oral Vaccines Value Forecast by Type (2021-2025) ($ Millions) Table 71. Global Oral Vaccines Value Market Share Forecast by Type (2021-2025) Table 72. Global Oral Vaccines Consumption Forecast by Application (2021-2025) (M Doses) Table 73. Global Oral Vaccines Consumption Market Share Forecast by Application (2021-2025) Table 74. Global Oral Vaccines Value Forecast by Application (2021-2025) ($ Millions) Table 75. Global Oral Vaccines Value Market Share Forecast by Application (2021-2025) Table 76. Merck Product Offered Table 77. Merck Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E) Table 78. Merck Main Business Table 79. Merck Latest Developments Table 80. Merck Basic Information, Company Total Revenue (in $ million), Oral Vaccines Manufacturing Base, Sales Area and Its Competitors Table 81. Vabiotech Product Offered Table 82. Vabiotech Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E) Table 83. Vabiotech Main Business Table 84. Vabiotech Latest Developments Table 85. Vabiotech Basic Information, Company Total Revenue (in $ million), Oral Vaccines Manufacturing Base, Sales Area and Its Competitors Table 86. GSK Product Offered Table 87. GSK Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E) Table 88. GSK Main Business Table 89. GSK Latest Developments Table 90. GSK Basic Information, Company Total Revenue (in $ million), Oral Vaccines Manufacturing Base, Sales Area and Its Competitors Table 91. Lanzhou Institute Product Offered Table 92. Lanzhou Institute Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E) Table 93. Lanzhou Institute Main Business Table 94. Lanzhou Institute Latest Developments Table 95. Lanzhou Institute Basic Information, Company Total Revenue (in $ million), Oral Vaccines Manufacturing Base, Sales Area and Its Competitors Table 96. Serum Institute Product Offered Table 97. Serum Institute Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E) Table 98. Serum Institute Main Business Table 99. Serum Institute Latest Developments Table 100. Serum Institute Basic Information, Company Total Revenue (in $ million), Oral Vaccines Manufacturing Base, Sales Area and Its Competitors Table 101. Sanofi Product Offered Table 102. Sanofi Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E) Table 103. Sanofi Main Business Table 104. Sanofi Latest Developments Table 105. Sanofi Basic Information, Company Total Revenue (in $ million), Oral Vaccines Manufacturing Base, Sales Area and Its Competitors Table 106. Bibcol Product Offered Table 107. Bibcol Basic Information, Company Total Revenue (in $ million), Oral Vaccines Manufacturing Base, Sales Area and Its Competitors Table 108. Bibcol Main Business Table 109. Bibcol Latest Developments Table 110. Bibcol Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E) Table 111. Valneva Product Offered Table 112. Valneva Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E) Table 113. Valneva Main Business Table 114. Valneva Latest Developments Table 115. Valneva Basic Information, Company Total Revenue (in $ million), Oral Vaccines Manufacturing Base, Sales Area and Its Competitors Table 116. PaxVax Product Offered Table 117. PaxVax Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E) Table 118. PaxVax Main Business Table 119. PaxVax Latest Developments Table 120. PaxVax Basic Information, Company Total Revenue (in $ million), Oral Vaccines Manufacturing Base, Sales Area and Its Competitors Table 121. Shanghai United Cell Product Offered Table 122. Shanghai United Cell Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E) Table 123. Shanghai United Cell Main Business Table 124. Shanghai United Cell Latest Developments Table 125. Shanghai United Cell Basic Information, Company Total Revenue (in $ million), Oral Vaccines Manufacturing Base, Sales Area and Its Competitors Table 126. Tiantan Biological Product Offered Table 127. Tiantan Biological Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E) Table 128. Tiantan Biological Main Business Table 129. Tiantan Biological Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 130. Tiantan Biological Latest Developments Table 131. Bio-Med Product Offered Table 132. Bio-Med Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E) Table 133. Bio-Med Main Business Table 134. Bio-Med Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 135. Bio-Med Latest Developments Table 136. Panacea Biotec Ltd Product Offered Table 137. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E) Table 138. Panacea Biotec Ltd Main Business Table 139. Panacea Biotec Ltd Latest Developments Table 140. Panacea Biotec Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 141. Halfkin Bio-Pharmaceuticals Product Offered Table 142. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E) Table 143. Halfkin Bio-Pharmaceuticals Main Business Table 144. Halfkin Bio-Pharmaceuticals Latest Developments Table 145. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 146. EuBiologics Product Offered Table 147. EuBiologics Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E) Table 148. EuBiologics Main Business Table 149. EuBiologics Latest Developments Table 150. EuBiologics Basic Information, Manufacturing Base, Sales Area and Its Competitors List of Figures Figure 1. Picture of Oral Vaccines Figure 2. Oral Vaccines Report Years Considered Figure 3. Market Research Methodology Figure 4. Global Oral Vaccines Consumption Growth Rate 2015-2025 (M Doses) Figure 5. Global Oral Vaccines Value Growth Rate 2015-2025 ($ Millions) Figure 6. Product Picture of Rotavirus Vaccine Figure 7. Product Picture of Cholera Vaccine Figure 8. Product Picture of Oral Polio Vaccine Figure 9. Product Picture of Others Figure 10. Global Oral Vaccines Consumption Market Share by Type (2015-2020) Figure 11. Global Oral Vaccines Value Market Share by Type (2015-2020) Figure 12. Oral Vaccines Consumed in Public Figure 13. Global Oral Vaccines Market: Public (2015-2020) (M Doses) Figure 14. Global Oral Vaccines Market: Public (2015-2020) ($ Millions) Figure 15. Oral Vaccines Consumed in Private Figure 16. Global Oral Vaccines Market: Private (2015-2020) (M Doses) Figure 17. Global Oral Vaccines Market: Private (2015-2020) ($ Millions) Figure 18. Global Oral Vaccines Consumption Market Share by Application (2015-2020) Figure 19. Global Oral Vaccines Value Market Share by Application (2015-2020) Figure 20. Global Oral Vaccines Sales Market Share by Company in 2017 Figure 21. Global Oral Vaccines Sales Market Share by Company in 2019 Figure 22. Global Oral Vaccines Revenue Market Share by Company in 2017 Figure 23. Global Oral Vaccines Revenue Market Share by Company in 2019 Figure 24. Global Oral Vaccines Sale Price by Company in 2019 Figure 25. Global Oral Vaccines Consumption Market Share by Regions 2015-2020 Figure 26. Global Oral Vaccines Value Market Share by Regions 2015-2020 Figure 27. Americas Oral Vaccines Consumption 2015-2020 (M Doses) Figure 28. Americas Oral Vaccines Value 2015-2020 ($ Millions) Figure 29. APAC Oral Vaccines Consumption 2015-2020 (M Doses) Figure 30. APAC Oral Vaccines Value 2015-2020 ($ Millions) Figure 31. Europe Oral Vaccines Consumption 2015-2020 (M Doses) Figure 32. Europe Oral Vaccines Value 2015-2020 ($ Millions) Figure 33. Middle East & Africa Oral Vaccines Consumption 2015-2020 (M Doses) Figure 34. Middle East & Africa Oral Vaccines Value 2015-2020 ($ Millions) Figure 35. Americas Oral Vaccines Consumption Market Share by Countries in 2019 Figure 36. Americas Oral Vaccines Value Market Share by Countries in 2019 Figure 37. Americas Oral Vaccines Consumption Market Share by Type in 2019 Figure 38. Americas Oral Vaccines Consumption Market Share by Application in 2019 Figure 39. United States Oral Vaccines Consumption Growth 2015-2020 (M Doses) Figure 40. United States Oral Vaccines Value Growth 2015-2020 ($ Millions) Figure 41. Canada Oral Vaccines Consumption Growth 2015-2020 (M Doses) Figure 42. Canada Oral Vaccines Value Growth 2015-2020 ($ Millions) Figure 43. Mexico Oral Vaccines Consumption Growth 2015-2020 (M Doses) Figure 44. Mexico Oral Vaccines Value Growth 2015-2020 ($ Millions) Figure 45. APAC Oral Vaccines Consumption Market Share by Countries in 2019 Figure 46. APAC Oral Vaccines Value Market Share by Regions in 2019 Figure 47. APAC Oral Vaccines Consumption Market Share by Type in 2019 Figure 48. APAC Oral Vaccines Consumption Market Share by Application in 2019 Figure 49. China Oral Vaccines Consumption Growth 2015-2020 (M Doses) Figure 50. China Oral Vaccines Value Growth 2015-2020 ($ Millions) Figure 51. Japan Oral Vaccines Consumption Growth 2015-2020 (M Doses) Figure 52. Japan Oral Vaccines Value Growth 2015-2020 ($ Millions) Figure 53. Korea Oral Vaccines Consumption Growth 2015-2020 (M Doses) Figure 54. Korea Oral Vaccines Value Growth 2015-2020 ($ Millions) Figure 55. Southeast Asia Oral Vaccines Consumption Growth 2015-2020 (M Doses) Figure 56. Southeast Asia Oral Vaccines Value Growth 2015-2020 ($ Millions) Figure 57. India Oral Vaccines Consumption Growth 2015-2020 (M Doses) Figure 58. India Oral Vaccines Value Growth 2015-2020 ($ Millions) Figure 59. Australia Oral Vaccines Consumption Growth 2015-2020 (M Doses) Figure 60. Australia Oral Vaccines Value Growth 2015-2020 ($ Millions) Figure 61. Europe Oral Vaccines Consumption Market Share by Countries in 2019 Figure 62. Europe Oral Vaccines Value Market Share by Countries in 2019 Figure 63. Europe Oral Vaccines Consumption Market Share by Type in 2019 Figure 64. Europe Oral Vaccines Consumption Market Share by Application in 2019 Figure 65. Germany Oral Vaccines Consumption Growth 2015-2020 (M Doses) Figure 66. Germany Oral Vaccines Value Growth 2015-2020 ($ Millions) Figure 67. France Oral Vaccines Consumption Growth 2015-2020 (M Doses) Figure 68. France Oral Vaccines Value Growth 2015-2020 ($ Millions) Figure 69. UK Oral Vaccines Consumption Growth 2015-2020 (M Doses) Figure 70. UK Oral Vaccines Value Growth 2015-2020 ($ Millions) Figure 71. Italy Oral Vaccines Consumption Growth 2015-2020 (M Doses) Figure 72. Italy Oral Vaccines Value Growth 2015-2020 ($ Millions) Figure 73. Russia Oral Vaccines Consumption Growth 2015-2020 (M Doses) Figure 74. Russia Oral Vaccines Value Growth 2015-2020 ($ Millions) Figure 75. Middle East & Africa Oral Vaccines Consumption Market Share by Countries in 2019 Figure 76. Middle East & Africa Oral Vaccines Value Market Share by Countries in 2019 Figure 77. Middle East & Africa Oral Vaccines Consumption Market Share by Type in 2019 Figure 78. Middle East & Africa Oral Vaccines Consumption Market Share by Application in 2019 Figure 79. Egypt Oral Vaccines Consumption Growth 2015-2020 (M Doses) Figure 80. Egypt Oral Vaccines Value Growth 2015-2020 ($ Millions) Figure 81. South Africa Oral Vaccines Consumption Growth 2015-2020 (M Doses) Figure 82. South Africa Oral Vaccines Value Growth 2015-2020 ($ Millions) Figure 83. Israel Oral Vaccines Consumption Growth 2015-2020 (M Doses) Figure 84. Israel Oral Vaccines Value Growth 2015-2020 ($ Millions) Figure 85. Turkey Oral Vaccines Consumption Growth 2015-2020 (M Doses) Figure 86. Turkey Oral Vaccines Value Growth 2015-2020 ($ Millions) Figure 87. GCC Countries Oral Vaccines Consumption Growth 2015-2020 (M Doses) Figure 88. GCC Countries Oral Vaccines Value Growth 2015-2020 ($ Millions) Figure 89. Global Oral Vaccines Consumption Growth Rate Forecast (2021-2025) (M Doses) Figure 90. Global Oral Vaccines Value Growth Rate Forecast (2021-2025) ($ Millions) Figure 91. Americas Oral Vaccines Consumption 2021-2025 (M Doses) Figure 92. Americas Oral Vaccines Value 2021-2025 ($ Millions) Figure 93. APAC Oral Vaccines Consumption 2021-2025 (M Doses) Figure 94. APAC Oral Vaccines Value 2021-2025 ($ Millions) Figure 95. Europe Oral Vaccines Consumption 2021-2025 (M Doses) Figure 96. Europe Oral Vaccines Value 2021-2025 ($ Millions) Figure 97. Middle East & Africa Oral Vaccines Consumption 2021-2025 (M Doses) Figure 98. Middle East & Africa Oral Vaccines Value 2021-2025 ($ Millions) Figure 99. United States Oral Vaccines Consumption 2021-2025 (M Doses) Figure 100. United States Oral Vaccines Value 2021-2025 ($ Millions) Figure 101. Canada Oral Vaccines Consumption 2021-2025 (M Doses) Figure 102. Canada Oral Vaccines Value 2021-2025 ($ Millions) Figure 103. Mexico Oral Vaccines Consumption 2021-2025 (M Doses) Figure 104. Mexico Oral Vaccines Value 2021-2025 ($ Millions) Figure 105. Brazil Oral Vaccines Consumption 2021-2025 (M Doses) Figure 106. Brazil Oral Vaccines Value 2021-2025 ($ Millions) Figure 107. China Oral Vaccines Consumption 2021-2025 (M Doses) Figure 108. China Oral Vaccines Value 2021-2025 ($ Millions) Figure 109. Japan Oral Vaccines Consumption 2021-2025 (M Doses) Figure 110. Japan Oral Vaccines Value 2021-2025 ($ Millions) Figure 111. Korea Oral Vaccines Consumption 2021-2025 (M Doses) Figure 112. Korea Oral Vaccines Value 2021-2025 ($ Millions) Figure 113. Southeast Asia Oral Vaccines Consumption 2021-2025 (M Doses) Figure 114. Southeast Asia Oral Vaccines Value 2021-2025 ($ Millions) Figure 115. India Oral Vaccines Consumption 2021-2025 (M Doses) Figure 116. India Oral Vaccines Value 2021-2025 ($ Millions) Figure 117. Australia Oral Vaccines Consumption 2021-2025 (M Doses) Figure 118. Australia Oral Vaccines Value 2021-2025 ($ Millions) Figure 119. Germany Oral Vaccines Consumption 2021-2025 (M Doses) Figure 120. Germany Oral Vaccines Value 2021-2025 ($ Millions) Figure 121. France Oral Vaccines Consumption 2021-2025 (M Doses) Figure 122. France Oral Vaccines Value 2021-2025 ($ Millions) Figure 123. UK Oral Vaccines Consumption 2021-2025 (M Doses) Figure 124. UK Oral Vaccines Value 2021-2025 ($ Millions) Figure 125. Italy Oral Vaccines Consumption 2021-2025 (M Doses) Figure 126. Italy Oral Vaccines Value 2021-2025 ($ Millions) Figure 127. Russia Oral Vaccines Consumption 2021-2025 (M Doses) Figure 128. Russia Oral Vaccines Value 2021-2025 ($ Millions) Figure 129. Spain Oral Vaccines Consumption 2021-2025 (M Doses) Figure 130. Spain Oral Vaccines Value 2021-2025 ($ Millions) Figure 131. Egypt Oral Vaccines Consumption 2021-2025 (M Doses) Figure 132. Egypt Oral Vaccines Value 2021-2025 ($ Millions) Figure 133. South Africa Oral Vaccines Consumption 2021-2025 (M Doses) Figure 134. South Africa Oral Vaccines Value 2021-2025 ($ Millions) Figure 135. Israel Oral Vaccines Consumption 2021-2025 (M Doses) Figure 136. Israel Oral Vaccines Value 2021-2025 ($ Millions) Figure 137. Turkey Oral Vaccines Consumption 2021-2025 (M Doses) Figure 138. Turkey Oral Vaccines Value 2021-2025 ($ Millions) Figure 139. GCC Countries Oral Vaccines Consumption 2021-2025 (M Doses) Figure 140. GCC Countries Oral Vaccines Value 2021-2025 ($ Millions) Figure 141. Merck Oral Vaccines Market Share (2018-2020) Figure 142. Vabiotech Oral Vaccines Market Share (2018-2020) Figure 143. GSK Oral Vaccines Market Share (2018-2020) Figure 144. Lanzhou Institute Oral Vaccines Market Share (2018-2020) Figure 145. Serum Institute Oral Vaccines Market Share (2018-2020) Figure 146. Sanofi Oral Vaccines Market Share (2018-2020) Figure 147. Bibcol Oral Vaccines Market Share (2018-2020) Figure 148. Valneva Oral Vaccines Market Share (2018-2020) Figure 149. PaxVax Oral Vaccines Market Share (2018-2020) Figure 150. Shanghai United Cell Oral Vaccines Market Share (2018-2020) Figure 151. Tiantan Biological Oral Vaccines Market Share (2018-2020) Figure 152. Bio-Med Oral Vaccines Market Share (2018-2020) Figure 153. Panacea Biotec Ltd Oral Vaccines Market Share (2018-2020) Figure 154. Halfkin Bio-Pharmaceuticals Oral Vaccines Market Share (2018-2020) Figure 155. EuBiologics Oral Vaccines Market Share (2018-2020)

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:
Publisher: LP Information Inc
Chat with us